how can we manage cll without worsening patients’ quality of life?
Published 7 years ago • 92 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
4:53
what leads to shorter progression-free survival in cll patients?
-
0:58
improving the long-term safety of cll treatment
-
12:46
fixed duration treatment strategies in cll
-
2:44
the main barriers to treatment access for patients with cll
-
1:26
how to help maintain the mental well-being of cll patients
-
2:19
long-term management of cll for improved outcomes
-
4:29
considering a patient with cll for a clinical trial and how to get them involved
-
1:00
using molecular features to determine appropriate treatment strategies for patients with cll
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
6:54
biomarker-guided treatment of cll in the chemo-free era
-
4:05
comparing continuous and fixed duration therapy in cll
-
0:57
unanswered questions in frontline cll treatment
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches
-
1:48
managing problems in treating cll
-
3:07
barriers to progressing cll treatment in taiwan: treatment access and biomarkers
-
2:29
the measurement of molecular biomarkers to aid cll treatment
-
1:05
strategies to prevent resistance in cll
-
1:33
key factors affecting treatment decision making in cll
-
0:59
treatment options for elderly cll patients or those with comorbidities beyond bcl2 inhibitors
-
1:12
testing drugs in isolated cells from patients with cll: advances and limitations
-
1:13
factors to consider when selecting between continuous and fixed-duration therapy in cll
-
3:29
how the management of cll is evolving